Renke Biotech Overview

  • Year Founded
  • 2021

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Early Stage VC

  • Investors
  • 6

Renke Biotech General Information

Description

Developer of screening products designed for cancer and clinical applications. The company offers cell culture systems, genetic analysis tools, and automated laboratory processes with scalable design, high sensitivity, and compatibility across multiple research environments, enabling healthcare institutions, academic laboratories, and biotechnology enterprises to improve diagnostic accuracy, accelerate experimental workflows, enhance data reliability, and medical development while supporting long-term innovation in life sciences.

Contact Information

Formerly Known As
Human Science (Beijing) Biotechnology Co., Ltd.
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • B215, 2nd Floor, Number 5, Kaituo Road
  • Haidian District
  • Beijing, 100085
  • China
+86 180
Primary Industry
Diagnostic Equipment
Other Industries
Other Devices and Supplies
Surgical Devices
Vertical(s)
Corporate Office
  • B215, 2nd Floor, Number 5, Kaituo Road
  • Haidian District
  • Beijing, 100085
  • China
+86 180

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Renke Biotech Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Early Stage VC 30-Apr-2025 Completed Generating Revenue
2. Early Stage VC 31-Jul-2024 Completed Generating Revenue
1. Seed Round 22-Sep-2022 Completed Startup
To view Renke Biotech’s complete valuation and funding history, request access »

Renke Biotech Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds
Innoangel Fund Venture Capital Minority
Zhehua Investment Venture Capital Minority
Autobio Diagnostics Company Corporation Minority
Huakong Electronics (Tianjin) Investment Management Growth/Expansion Minority
Tsinghua Innovation Ventures Venture Capital Minority
You’re viewing 5 of 6 investors. Get the full list »

Renke Biotech FAQs

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process